Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study

The authors compared vitamin E with placebo in a double-blind randomized crossover study of 27 patients with tardive dyskinesia. Each treatment period lasted for 6 weeks. Vitamin E showed no differences from placebo in the treatment of tardive dyskinesia.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of psychiatry 1992-03, Vol.149 (3), p.391-393
Hauptverfasser:	SHRIQUI, C. L, BRADWEJN, J, ANNABLE, L, JONES, B. D
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Antipsychotic Agents - adverse effects Biological and medical sciences Bipolar Disorder - drug therapy Double-Blind Method Dyskinesia, Drug-Induced - drug therapy Dyskinesia, Drug-Induced - etiology Dyskinesia, Drug-Induced - physiopathology Female Humans Male Medical disorders Medical sciences Middle Aged Miscellaneous Nervous system Neuropharmacology Pharmacology. Drug treatments Physical Examination Placebos Schizophrenia - drug therapy Social research Vitamin E - therapeutic use Vitamins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The authors compared vitamin E with placebo in a double-blind randomized crossover study of 27 patients with tardive dyskinesia. Each treatment period lasted for 6 weeks. Vitamin E showed no differences from placebo in the treatment of tardive dyskinesia.
ISSN:	0002-953X 1535-7228
DOI:	10.1176/ajp.149.3.391